Company · CIK 1538927
Forma Therapeutics Holdings, Inc.
| CIK | 1538927 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2020-08-13 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-258174 | 2021-07-26 | 2022-10-17 | 3 | |
| 333-251198 | 2020-12-08 | 2020-12-11 | 3 | |
| 333-238783 | 2020-05-29 | 2020-06-22 | 4 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-10-17 | EFFECTDeclared effective | 333-258174 | 9999999995-22-003054 |
| 2022-05-03 | EFFECTDeclared effective | 333-258174 | 9999999995-22-001277 |
| 2021-07-26 | S-3ASRShelf registered | 333-258174 | 0001193125-21-224328 |
| 2020-12-11 | 424B4Final prospectus | 333-251198 | 0001193125-20-315875 |
| 2020-12-10 | EFFECTDeclared effective | 333-251198 | 9999999995-20-003491 |
| 2020-12-08 | S-1Registration filed | 333-251198 | 0001193125-20-312817 |
| 2020-11-13 | DRSDraft made public | 377-03783 | 0000950123-20-011836 |
| 2020-06-22 | 424B4Final prospectus | 333-238783 | 0001193125-20-175707 |
| 2020-06-18 | EFFECTDeclared effective | 333-238783 | 9999999995-20-001476 |
| 2020-06-15 | S-1/AAmendment | 333-238783 | 0001193125-20-168273 |
| 2020-05-29 | S-1Registration filed | 333-238783 | 0001193125-20-155670 |
| 2020-04-08 | DRSDraft made public | 377-03114 | 0000950123-20-003193 |